SHEILA PATTERSON: Open Payments
NPI 1700267259 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,104 in 127 payments from 12 companies in 2025. Trend: 2023 $1,615 · 2024 $2,229 · 2025 $2,104
Food & beverage: $2,104
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $716 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $268 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 21 | $228 |
| Gilead Sciences, Inc. | 9 | $228 |
| Madrigal Pharmaceuticals | 8 | $135 |
| Ardelyx, Inc. | 5 | $107 |
| Phathom Pharmaceuticals, Inc. | 12 | $101 |
| QOL Medical, LLC | 3 | $80 |
| Janssen Biotech, Inc. | 3 | $69 |
| Ipsen Biopharmaceuticals, Inc | 4 | $67 |
Products named: ENTYVIO, XIFAXAN, RINVOQ, LINZESS, MAVYRET, REZDIFFRA, Livdelzi, CREON.
Industry payments across TX — which companies pay providers there.
